Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCNA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
mRNA | AP1B1 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | NCAPH2 | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
mRNA | CTNND2 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | SDC4 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | TCEAL2 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | C15orf61 | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
mRNA | UBE2QL1 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | GP1BB | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
mRNA | BAG2 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |